Industrial-Scale Proteomics for Drug Discovery

A $9 billion valuation fell to zero. The record on Theranos shows which warning signs were visible early, and what technical buyers can check before they trust a bold claim.

Three new free clones target Excel, PowerPoint and Word. Here is what the reporting establishes, what it leaves out, and a practical checklist for testing them.

Ticket tier, pitch applications and afternoon-only opening hours shape how useful two days at Startup Nights in Winterthur will be. Here is what is confirmed and what is not.